Risofos 150 mg
Risofos 150 mg
Risofos 150 mg is a prescription medicine used to treat or prevent the weakening of the bones (osteoporosis) caused by menopause or the use of steroids. It reduces the incidence of vertebral and nonvertebral osteoporosis-related fractures in postmenopausal women with osteoporosis. The medicine contains the active ingredient Risedronate, one of the bisphosphonate drug treatments widely used to reduce the risk of broken bones in people with osteoporosis.
How to use
To facilitate delivery to the stomach, Risofos should be swallowed while the patient is in an upright position and with a glass of plain water. Follow a prescription schedule issued by your doctor. In common, Risofos is best taken without food. Take it at least thirty minutes before the first food or drink of the day. You should take it regularly as per schedule. The recommended dose is 150 mg once monthly for osteoporosis in postmenopausal women. The optimal duration of use has not been determined for patients at low risk for fracture; consider drug discontinuation after 3 to 5 years of use.
Patients should receive supplemental calcium and vitamin D if dietary intake is inadequate. Calcium supplements, calcium-aluminium, and magnesium-containing medications may interfere with the absorption of Risedronate and should be taken at different times of the day. The medicine is not recommended for use in patients with severe renal impairment. No dose adjustment is necessary for elderly patients.
Risofos should not be used in people with:
- Hypoglycaemia (abnormally low levels of glucose)
- Inability to stand or sit upright for at least thirty minutes.
- Known hypersensitivity to any component of this product.
Upper gastrointestinal irritation may occur. Proper dosing instructions should be followed. Discontinue treatment if new or worsening symptoms occur. If you are already dealing with Hypoglycaemia, your condition may worsen and must be corrected before use. Severe joint, bone, or muscle pain may occur.
Consider treatment discontinuation if you develop severe symptoms. Before initiating treatment in patients with glucocorticoid-induced osteoporosis, the sex steroid hormonal status of both men and women should be ascertained, and appropriate replacement considered. Risedronate may interfere with bone imaging agents.
Side effects associated with Risofos 150 mg include:
- Inflamed food pipe, sore throat, heartburn, and swallowing difficulties. Make sure the tablet doesn’t stick in your food pipe, where it can irritate you to remain standing or sit for at least half an hour after swallowing the tablet with a glass of plain water. If you get heartburn that doesn’t resolve, please talk to your doctor.
- Bone, joint, or muscle pain may occur. This is sometimes an initial response that often improves as your body adjusts to the new medicine and may be alleviated by taking a pain reliever drug such as paracetamol. Occasionally, this is a long-term problem, so talk to your doctor about the treatment options.
- Headache for which you can take a simple pain reliever like paracetamol, although if the headache continues, speak with your doctor.
- Inflammation of the eye causes eye pain or disturbed vision. If you have an existing inflammatory eye disease or develop any symptoms such as painful red eyes, you should immediately see your doctor.